Home > News > Content

EMCDDA And ECDC Work Together To Tackle The Challenges Of Hepatitis

Jul 17, 2017

Hepatitis and other related infectious diseases will become the focus of hepatitis weeks' in the EU drug agency (drug) from 12 to 16 June in Lisbon (1). The proposal bring together 100 experts from EU member countries, candidate countries and potential candidates, as well as EU partner institutions, civil society and professional organizations

Viral hepatitis, especially for the hepatitis C virus (HCV) -induced infections, is popular among injecting drug users in Europe. Each 100 people infected with hepatitis C virus (antibody positive),however, it is about 75 to 80 people developed into chronic infection.